Yasuhiro Kimura Selected Research

3-methoxytyrosine

1/2012	Effects of 3-O-methyldopa, L-3,4-dihydroxyphenylalanine metabolite, on locomotor activity and dopamine turnover in rats.
9/2011	Relationship between 3-O-methyldopa and the clinical effects of entacapone in advanced Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Kimura Research Topics

Disease

2	Bipolar Disorder (Manic Depressive Psychosis) 01/2020 - 03/2013
2	Hypoglycemia (Reactive Hypoglycemia) 01/2013 - 04/2007
2	Parkinson Disease (Parkinson's Disease) 01/2012 - 09/2011
1	Myocarditis (Carditis) 12/2020
1	Cytokine Release Syndrome 12/2020
1	Atrioventricular Block 12/2020
1	Renal Insufficiency (Renal Failure) 12/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2020
1	Pericarditis 12/2020
1	Mania (Manias) 01/2020
1	Hyperplasia 11/2016
1	Cataract (Cataracts) 01/2016
1	Carcinogenesis 09/2015
1	Neoplasms (Cancer) 09/2015
1	Acute Radiation Syndrome 04/2015
1	Reperfusion Injury 01/2015
1	Ischemia 01/2015
1	Hypotension (Low Blood Pressure) 01/2015
1	Corneal Injuries 11/2014
1	Cholelithiasis 03/2014
1	Pancreaticobiliary Maljunction 03/2014
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 03/2014
1	Asthma (Bronchial Asthma) 03/2012
1	Fever (Fevers) 03/2012
1	Bronchitis 03/2012
1	Hypersensitivity (Allergy) 04/2003
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2002
1	Alzheimer Disease (Alzheimer's Disease) 01/2002
1	Hypertension (High Blood Pressure) 01/2002

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 04/2003
2	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 09/2015 - 03/2014
2	FluoroquinolonesIBA 01/2013 - 04/2007
2	3-methoxytyrosineIBA 01/2012 - 09/2011
2	Levodopa (L Dopa)FDA LinkGeneric 01/2012 - 09/2011
1	CytokinesIBA 12/2020
1	GlucocorticoidsIBA 12/2020
1	Clarithromycin (Biaxin)FDA LinkGeneric 11/2016
1	Messenger RNA (mRNA)IBA 11/2016
1	Chloride Channels (Chloride Channel)IBA 11/2016
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2016
1	SolutionsIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 09/2015
1	lysophosphatidic acidIBA 04/2015
1	octadecenyl thiophosphateIBA 04/2015
1	Y 27632IBA 01/2015
1	rho-Associated KinasesIBA 01/2015
1	IodineIBA 11/2014
1	Povidone-Iodine (Betadine)FDA LinkGeneric 11/2014
1	Nonesterified Fatty Acids (NEFA)IBA 03/2014
1	Phospholipases A2 (Phospholipase A2)IBA 03/2014
1	Phosphatidylcholines (Phosphatidylcholine)IBA 03/2014
1	Valproic Acid (Depakote)FDA LinkGeneric 03/2013
1	Adenosine Triphosphate (ATP)IBA 01/2013
1	Theophylline (Theon)FDA LinkGeneric 03/2012
1	Aminophylline (Carine)FDA LinkGeneric 03/2012
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 01/2012
1	Dopa DecarboxylaseIBA 09/2011
1	entacapone (Comtan)FDA Link 09/2011
1	Carbapenems (Carbapenem Antibiotics)IBA 04/2003
1	Penicillins (Penicillin)FDA Link 04/2003
1	Cephalosporins (Cephalosporin Antibiotics)IBA 04/2003
1	tau Proteins (tau Protein)IBA 01/2002
1	CreatinineIBA 01/2002
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2002
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2002
1	Proteins (Proteins, Gene)FDA Link 01/2002

Therapy/Procedure

3	Therapeutics 12/2020 - 01/2012
1	Hemodiafiltration 12/2020
1	Plasma Exchange 12/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Intravenous Infusions 03/2012